ROBO1 and hepatocellular carcinoma: We have developed an anti-Robo1 monoclonal antibody [28] and showed the antitumor effects of an isotope-labelled version of this antibody against hepatocellular carcinoma and small cell lung cancer xenografts [29, 30].